Enliven Therapeutics, Inc.ELVNNASDAQ
Loading
Sum of short-term and long-term debt obligations
3Y CAGR
+7.3%/yr
Annual compound
Percentile
P88
Within normal range
vs 3Y Ago
1.2x
Modest growth
Streak
1 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $399000.00 | - |
| 2024 | $0.00 | -100.0% |
| 2023 | $335000.00 | +3.7% |
| 2022 | $323000.00 | +103.1% |
| 2021 | $159000.00 | - |
| 2020 | $0.00 | - |
| 2019 | $0.00 | - |
| 2018 | $0.00 | -100.0% |
| 2017 | $660000.00 | - |